Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
about
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationDetection of hepatic metastases using ferucarbotran-enhanced MR imaging: feasibility and diagnostic accuracy of three-dimensional sensitivity-encoding water-excitation multishot echo-planar sequence (3D-SWEEP).Magneto-motive detection of tissue-based macrophages by differential phase optical coherence tomography.A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.What is the current situation in liver imaging?MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.Malignant biliary obstruction: value of imaging findings.Molecular imaging of tumor invasion and metastases: the role of MRI.Characterization of focal hepatic lesions with SPIO-enhanced MRI.The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI.Liver metastases of colorectal cancer: US, CT or MR?Superparamagnetic iron oxide nanoparticle probes for molecular imaging.New MR techniques for the detection of liver metastasesIntra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T.Role of preoperative local and distant staging in rectal cancer.Contrast agents for hepatic MRI.Nanoplatforms for targeted molecular imaging in living subjects.Intrahepatic extramedullary hematopoiesis mimicking a hypervascular hepatic neoplasm on dynamic- and SPIO-enhanced MRI.Inorganic nanoparticles for predictive oncology of breast cancer.The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.Resovist-enhanced MRI for preoperative assessment of colorectal hepatic metastases: a case of multiple bile duct hamartomas associated with colon cancer.Magnetic nanoparticles and their applications in image-guided drug delivery.Using Nanoparticles in Medicine for Liver Cancer Imaging.Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.A carbon-wrapped nanoscaled thermometer for temperature control in biological environments.Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location.Group sequential design for comparative diagnostic accuracy studies.MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions.Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.[Diagnostic imaging of liver tumours. Current status].Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners.
P2860
Q24613744-F02CE58C-8131-4B08-B7EA-CD42DCCC2BFCQ31065643-93EC3D25-50EB-4C74-A927-313A2B5971E1Q33273383-0A0BC410-7E0F-4C72-B3A2-7A6620F0FC87Q33585177-6EF74980-573C-45BB-8EF9-7803BFB95743Q34369626-9564972A-909E-44D6-90B3-D4E29EF6CE39Q35688711-DE346447-E0F4-4581-92C7-15022F54B22CQ36116979-8EB09ABB-70E6-4195-B8E2-32191E82A7BCQ36167800-4BA76413-9FD9-4FAA-A665-6F0DC388F08BQ36204115-E549215E-4F68-4EF7-B99B-517F5932983FQ36309136-18ECF1BC-D584-4B5F-B46D-CD7E01597BE3Q36324045-4670962B-596F-4657-98B3-3243FFBD7E00Q36345336-B5ACDD56-6500-4810-8DA7-9D7B059DA858Q36404175-D12F62C6-8BA1-4562-9409-A15245FDD5E4Q36502861-8951A671-5171-4706-AE41-57ACEB51DDF2Q36685129-05A34B02-4BA6-4D20-84F8-AEDEDB9B8D58Q36753224-2E900757-7549-4C17-9775-794405D1B065Q36963721-166B3214-9AA5-4862-A7FE-74A03B15BAC3Q36974486-11A09D1A-09BD-483C-AA3F-6A87B8061F6AQ37063025-0FBC1C2B-FC27-42FB-91BC-0FF1F62E0597Q37354229-ED4CF82F-F8B8-4171-95EC-CEC06EA677AEQ37638186-5E613B66-7E36-498B-8216-823BBFDC32F9Q38090392-77CC7C96-1B46-43E9-AC99-8487B7F92399Q38303455-00D69710-5EDB-42ED-B1B5-A13CB32AD948Q38382957-280D1169-7BB5-4559-B3D8-55CBEE4E1F36Q42339350-4F88CC59-E76E-4D27-B8FB-8CBEE05E7E75Q45076926-5629B909-6674-45D4-B4B5-7361FC4BC79AQ45187675-B4B26106-D24A-43B4-A565-C3D5D29760EEQ46923851-0622A213-83AA-4CE7-B84C-8E492E7B478CQ47266214-BA95DFF8-DBD5-463E-B6EB-A020E724B145Q51639836-72360C93-1542-4A33-9A2A-2BF8E4C96D87Q51652107-82EAB11A-7435-4E1F-947A-967A2E8EDB97Q53001065-A13B74EA-D275-4422-9B4E-6FCA40DED647Q53116231-C4CE0FB6-9C24-4DDD-BEC8-0C3F168D2DA3Q53170580-A19C11A9-286F-491D-A42F-20BD1C50FF93Q53297914-FBB9B453-B005-425B-8394-C1D457769AA5Q53307405-F9810067-CB95-47FB-BED9-A184139BCA99Q53407578-B3B2CE19-A120-4F08-8F2A-D19F39DF69A6Q53496562-75B9D1A2-D938-4660-9F24-2C7836B02618Q53504739-1E4779A1-495E-40E1-8B54-9CB98D378645Q53611974-C72C084F-782E-478D-8BE3-ED13D82F921B
P2860
Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@ast
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@en
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@nl
type
label
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@ast
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@en
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@nl
prefLabel
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@ast
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@en
Hepatic lesion detection and c ...... g, and spiral CT-ROC analysis.
@nl
P2093
P1433
P1476
Hepatic lesion detection and c ...... ng, and spiral CT-ROC analysis
@en
P2093
N Holzknecht
P304
P356
10.1148/RADIOLOGY.217.1.R00OC31152
P407
P50
P577
2000-10-01T00:00:00Z